Clinical Trial Update: Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Completion report for a Phase 1/Phase 2 clinical study evaluating capecitabine, oxaliplatin, and bevacizumab in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED